TMO vs BMY
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Bristol-Myers Squibb Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | BMY |
|---|---|---|
| Price | $700.22 | $63.43 |
| Market cap | $259.44B | $129.66B |
| P/E ratio | 36.9 | 14.1 |
| ROE | 13.38% | 44.01% |
| Profit margin | 14.94% | 18.47% |
| Revenue growth | 9.10% | 6.90% |
| Dividend yield | 0.27% | 3.97% |
| Beta | 0.84 | 0.19 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs BMY in plain English
- TMO is the bigger company — about 2.0× the market cap of BMY.
- BMY is cheaper on earnings (P/E 14.1 vs 36.9).
- BMY earns a higher return on equity (44% vs 13%).
- TMO is growing revenue faster (9% vs 7%).
- BMY has the higher dividend yield (3.97% vs 0.27%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
BMY return calculator
See what $1,000 in Bristol-Myers Squibb Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.